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Abstract: The biocontrol agent Lysobacter enzymogenes OH11 produces several structurally distinct
antibiotic compounds, including the antifungal HSAF (Heat Stable Antifungal Factor) and alteramides,
along with their 3-dehydroxyl precursors (3-deOH). We previously showed that the 3-hydroxylation is
the final step of the biosynthesis and is also a key structural moiety for the antifungal activity. However,
the procedure through which OH11 regulates the 3-hydroxylation is still not clear. In OH11, the gene
orf3232 was predicted to encode a TetR regulator (LeTetR) with unknown function. Here, we deleted
orf3232 and found that the LeTetR mutant produced very little HSAF and alteramides, while the
3-deOH compounds were not significantly affected. The production of HSAF and alteramides was
restored in orf3232-complemented mutant. qRT-PCR showed that the deletion of orf3232 impaired
the transcription of a putative fatty acid hydroxylase gene, orf2195, but did not directly affect the
expression of the HSAF biosynthetic gene cluster (hsaf ). When an enzyme extract from E. coli
expressing the fatty acid hydroxylase gene, hsaf -orf7, was added to the LeTetR mutant, the production
of HSAF and alteramides increased by 13–14 fold. This study revealed a rare function of the TetR
family regulator, which positively controls the final step of the antifungal biosynthesis and thus
controls the antifungal activity of the biocontrol agent.
Keywords: natural product; HSAF; alteramides; regulation; Lysobacter enzymogenes
1. Introduction
Lysobacter is a genus of Gram-negative gliding bacteria inhabiting soil and fresh water [1]. Natural
products with distinct chemical structures and biological activities have been identified from the
Lysobacter species that are recognized as a new source of antibiotics (Figure 1A) [2]. HSAF belonging to
the family of polycyclic tetramate macrolactams (PoTeM) is a predominate natural product of Lysobacter
enzymogenes [3,4]. It exhibits a broad-spectrum antifungal activity with a novel mode of action and has
the potential as a novel lead compound for fungicides or antifungal drugs [5–7].
The regulation of HSAF biosynthesis involves a complex network including two-component
regulatory systems (TCS), transcription regulators, and small-molecule signaling factors. Previous
studies showed that several signal pathways, such as the TCS Rpf/DSF (diffusible signal factor),
DF (diffusible factor), and Clp (cyclic adenosine monophosphate-receptor-like protein), are critical to
the biosynthesis of HSAF [8–18]. In the Rpf/DSF pathway, the signal molecule LeDSF3 promotes the
HSAF production and Clp expression [8]. In the DF pathway, the LysR-family regulator LysRLe binds to
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the promoter region of HSAF biosynthetic gene and induces the gene expression and HSAF production,
after binding with its ligand 4-hydroxybenzoic acid (4-HBA) [11]. In addition, the MarR-family regulator
LarR promotes the HSAF biosynthesis by binding to the promoter region of the HSAF biosynthetic
gene, and is negatively controlled by 4-HBA but positively controlled by LysRLe [12]. In the Clp
pathway, an acetyltransferase Lat that is regulated by Clp is involved in the HSAF biosynthesis [10].
A TetR-family regulator LetR inhibits the HSAF biosynthetic genes expression and HSAF production
by binding to the promoter of the biosynthetic gene [13]. The TCS response regulator PilG negatively
controls the HSAF production, while another TCS response regulator PilR induces the biosynthesis of
HSAF by affecting the in vivo concentration of cyclic di-GMP [14,15]. Cyclic di-GMP regulates the
HSAF biosynthesis by controlling the binding of Clp with its binding sites in the HSAF promoter [16]
and maintaining a proper cellular concentration of spermidine, which is shown to be critical to the
HSAF production [17,18]. Overall, the previous studies mainly focused on the regulation of the final
product HSAF of the biosynthetic pathway.
Apart from HSAF, L. enzymogenes also produces several PoTeM analogs including alteramides
and their 3-dehydroxy forms, 3-deOH HSAF, and 3-deOH alteramides (Figure 1A). Our previous
study has shown that 3-hydroxylation is the final step in the biosynthesis of PoTeM, and the fatty acid
hydroxylase SD that is encoded by orf7 of the hsaf gene cluster is required for the 3-hydroxylation [19].
The study also indicated that the 3-OH moiety is critical to the antifungal activity of HSAF. However,
it remains unclear as to how L. enzymogenes controls the production of the active 3-OH compounds
versus the barely active 3-deOH compounds. In this work, we found that a new TetR-family regulator,
LeTetR encoded by orf3232 in L. enzymogenes OH11, positively regulates the 3-hydroxylation of HSAF
and its analogs, but does not affect the production of 3-deOH HSAF and 3-deOH alteramides.
2. Results
2.1. LeTetR Regulates the Production of HSAF and Alteramides
Genome annotation of L. enzymogenes OH11 predicted that orf3232 encodes a TetR regulator
(here named LeTetR). LeTetR contained the DNA-binding domain at the C-terminus and RutR domain,
which might be related to the ligand binding at the N-terminus (Figure S1). Since the TetR family
regulators are known to regulate antibiotics production, we deleted the orf3232 gene (∆ORF3232)
(Figure S2) and examined the impact on the production of the most predominant antibiotics in strain
OH11, HSAF, and the analogs (Figure 1A). HPLC analysis showed that the production of HSAF and
alteramides in ∆ORF3232 decreased significantly, to about 20% of that in the wild type (WT), while the
production of 3-deOH HSAF and 3-deOH alteramides increased slightly (Figure 1B,C). When the
orf3232 gene was reintroduced into the mutant, the complementary strain (ORF3232CM) (Figure S3)
restored the production of HSAF and alteramides to the WT level, while the level of 3-deOH HSAF
and 3-deOH alteramides was nearly unaffected in ORF3232CM (Figure 1B,C).
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Figure 1. The antifungal HSAF and its analogs and impact of the deletion of the TetR family regulator, 
LeTetR, on their production in L. enzymogenes OH11. (A) Chemical structure of HSAF and its analogs 
produced in L. enzymogenes OH11. (B) HPLC analysis of HSAF and its analogs in strains WT, ΔORF3232 
and ORF3232CM cultured in 1/10 TSB (Tryptic Soy Broth) medium for 48 h. (C) Quantification of HSAF 
and its main analogs in these strains. Note: As the 3-deOH alteramides were minor compounds and not 
well resolved from 3-deOH HSAF in HPLC, only 3-deOH HSAF was presented in the quantification. 
White columns, WT; light-gray columns, ΔORF3232; dark-gray columns, ORF3232CM. Data are presented 
as averages of three independent experiments, each conducted in triplicates, with * p < 0.05; ** p < 0.01. 
The results indicated that LeTetR might participate in the regulation of the 3-hydroxylation of HSAF 
and alteramides. Our previous study showed that orf7 (fatty acid hydroxylase gene, or SD gene) in the 
HSAF biosynthetic gene cluster (hsaf) is required for the 3-hydroxylation of HSAF, and orf8 (ferredoxin 
reductase gene, or the FNR gene) enhanced this process [19]. We thus suspected that LeTetR might 
regulate the transcription of orf7 and orf8 to affect the production of the 3-hydroxyl compounds, HSAF 
and alteramides. Surprisingly, qRT-PCR results showed that the transcription of orf7 and orf8, as well as 
the HSAF polyketide-nonribosomal peptide synthetase gene, hsaf-pks-nrps, was not significantly changed 
Figure 1. The antifungal S F and its analogs and impact of the deletion of the TetR family regulator,
LeTetR, on their production in L. enzymogenes OH11. (A) Chemical structure of HSAF and its analogs
produced in L. enzymogenes O 11. (B) PLC analysis of HSAF and its analogs in strains WT, ∆ORF3232
and ORF3232C cultured in 1/10 TSB (Tryptic Soy Broth) medium for 48 h. (C) Quantification of HSAF
and its main analogs in these strains. Note: As the 3-deOH alteramides were minor compounds and not
well resolved from 3-deOH HSAF in HPLC, only 3-deOH HSAF was presented in the quantification.
White columns, WT; light-gray columns, ∆ORF3232; dark-gray columns, ORF3232CM. Data are
presented as averages of three independent experiments, each conducted in triplicates, with * p < 0.05;
** p < 0.01.
The results indicated that LeTetR might participate in the regulation of the 3-hydroxylation of
HSAF and alteramides. Our previous study showed that orf7 (fatty acid hydroxylase gene, or SD gene)
in the HSAF biosynthetic gene cluster (hsaf ) is required for the 3-hydroxylation of HSAF, and orf8
(ferredoxin reductase gene, or the FNR gene) enhanced this process [19]. We thus suspected that
LeTetR might regulate the transcription of orf7 and orf8 to affect the production of the 3-hydroxyl
compounds, HSAF and alteramides. Surprisingly, qRT-PCR results showed that the transcription of
orf7 and orf8, as well as the HSAF polyketide-nonribosomal peptide synthetase gene, hsaf-pks-nrps,
was not significantly changed in the mutant strain ∆ORF3232 (Figure S4). This led us to search for other
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putative fatty acid hydroxylase genes, outside the HSAF biosynthetic gene cluster. Three candidate
genes (orf2195, orf4890, and orf5031) were found from the OH11 genome (Figure S5). The transcription
of orf2195 was significantly decreased in the strain ∆ORF3232 and restored to the WT level in the strain
ORF3232CM, when cultured for 9 h, and then almost could not be detected in all three strains, after 24 h
and 36 h (Figure 2). In contrast, the transcription of orf4890 and orf5031 did not change significantly
between strain ∆ORF3232 and ORF3232CM (Figure 2).
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Figure 2. Transcription analysis of fatty acid hydroxylase genes (orf2195, orf4890, and orf5031) in OH11
cultured in 1/10 TSB medium. White columns, WT; light-gray columns, ∆ORF3232; and dark-gray
columns, ORF3232CM. Data are presented as averages of the three independent experiments,
each conducted in triplicates, with ** p < 0.01.
The result suggested that the LeTetR positively regulated the transcription of orf2195, and ORF2195
in turn might also contribute to the conversion of 3-deOH HSAF and 3-deOH alteramides to HSAF and
alteramides. To test this hypothesis, we deleted orf2195 (∆ORF2195), as well as orf7 (∆ORF7) (Figures S6
and S7) and analyzed the compounds in the deletion mutants. The HPLC results showed that the
level of the compounds in strain ∆ORF2195 was similar to that in WT, indicating orf2195 alone did not
play a significant role in the 3-hydroxylation (Figure 3). However, the level of HSAF and alteramides
in strain ∆ORF7 was significantly reduced, while the level of 3-deOH HSAF (also probably 3-deOH
alteramides) increased slightly (Figure 3). The result is consistent with the previous study [19] and
revealed that, while ORF7 (SD) is the main enzyme for 3-hydroxylation, other fatty acid hydroxylases,
such as ORF2195, are also likely to contribute to the conversion of 3-deOH compounds to HSAF and
alteramides (Figure 3). Finally, we generated a double deletion mutant (∆ORF7-ORF2195), by deleting
both orf2195 and orf7 (Figure S8). The level of HSAF and alteramides in strain ∆ORF7-ORF2195 further
decreased when compared to that of strain ∆ORF7 or strain ORF2195 (Figure 3), supporting that
ORF2195 plays a role in HSAF 3-hydroxylation.
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and alteramides dramatically increased (14-fold and 13-fold, respectively) in the ΔORF3232 culture. In 
addition, the 3-deOH compounds remained at a high level in ΔORF3232, with the addition of the E. coli 
enzyme extract (Figure 4). This showed that the Lysobacter strain ΔORF3232 continually produced the 3-
deOH compounds, while a large portion of the 3-deOH compounds were converted to HSAF and 
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Figure 3. Production of HSAF and its analogs in deletion mutants of fatty acid hydroxylase genes in
L. enzymogenes OH11. (A) HPLC analysis of HSAF and its analogs in strains WT, ∆ORF2195, ∆ORF7,
and∆ORF7-∆ORF2195, cultured in 1/10 TSB medium for 48 h. (B) Quantification of HSAF and its analogs
in these strains. White columns, WT; light-gray columns, ∆ORF2195; medium-gray columns, ∆ORF7;
dark-grey columns, ∆ORF7-∆ORF2195. Note: As the 3-deOH alteramides were minor compounds and
not well-resolved from 3-deOH HSAF in HPLC, only 3-deOH HSAF was presented in the quantification.
Data are presented as the averages of the three independent experiments, each conducted in triplicates,
with * p < 0.05; ** p < 0.01.
2.2. Bioconversion of 3-deOH Compounds in the LeTetR Mutant to HSAF and Alteramides Using an Enzyme
Extract from the E. coli-Expressing orf7 Gene
The above results confirmed that the fatty acid hydroxylase encoded by orf7 (SD gene) in the
HSAF biosynthetic gene cluster is the main player in the 3-hydroxylation of HSAF. This inspired us to
test the bioconversion of the 3-deOH compounds produced in the LeTetR mutant, ∆ORF3232, using the
E. coli-carrying hsaf-orf7 gene. When the E. coli extract was added to the Lysobacter culture of ∆ORF3232,
HSAF and alteramides dramatically increased (14-fold and 13-fold, respectively) in the ∆ORF3232
culture. In addition, the 3-deOH compounds remained at a high level in ∆ORF3232, with the addition
of the E. coli enzyme extract (Figure 4). This showed that the Lysobacter strain ∆ORF3232 continually
produced the 3-deOH compounds, while a large portion of the 3-deOH compounds were converted to
HSAF and alteramides by the E. coli-expressed enzyme. The results confirmed the 3-hydroxylation
function of hsaf-orf7 and also revealed a potentially robust bioconversion for production of the active
PoTeM compounds (HSAF and alteramides), by using the LeTetR mutant as a cell factory.
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3. Discussion
The TetR family regulators are typically repressor proteins that negatively control the gene
expression in many cellular processes, such as antibiotic resistance, biosynthesis, pathogenesis, and
response to cell stress [20]. In this study, we investigated the function of a TetR regulator (LeTetR)
encoded by orf3232 in L. enzymogenes OH11. When this gene was deleted, the production of the
3-hydroxyl products, HSAF and alteramides, was significantly reduced, while the production of their
biosynthetic precursors, 3-deOH HSAF and 3-deOH alteramides, was not apparently affected (Figure 1).
This shows that LeTetR positively regulates the 3-hydroxylation step in the production of this family of
antifungal natural products. It also suggests that LeTetR might selectively control the final step in the
biosynthesis, which is key to the conversion of the barely active precursors, the 3-deOH compounds,
to the highly active final products—HSAF and alteramides. Wang et al. previously studied a TetR
regulator (LetR) in OH11, which is encoded by orf0953 [13]. Their results showed that LetR negatively
regulated HSAF production, through a transcription repression by directly binding to the promoter
(PHSAF) of the HSAF biosynthetic gene cluster. The LetR-regulated HSAF biosynthesis was due to
the direct control of the transcription of the biosynthetic gene (including the key biosynthetic gene
hsaf-pks-nrps). However, our results show that LeTetR did not appear to directly affect the transcription
of hsaf-pks-nrps, or the associated genes in the cluster, such as orf7 (SD gene) and orf8 (FNR gene) for
3-hydroxylation (Figure S4). In search for other putative fatty acid hydroxylase genes that might be
controlled by LeTetR and so might contribute to the 3-hydroxylation, we found the transcription of one
gene, orf2195, was clearly impaired upon deletion and restored upon complementation of the regulator
LeTetR gene, orf3232 (Figure 2). However, orf2195 appeared to play a minor role in the 3-hydroxylation,
because the deletion of orf2195 only had a minor effect on the 3-hydroxyl products. When both orf2195
and orf7 were deleted, the 3-hydroxyl products were barely detectable, while the accumulation of the
3-deOH products increased in the double deletion mutant (Figure 3). Together, the results revealed an
unusual TetR type regulator that positively controlled the final step of the HSAF biosynthetic pathway.
Despite the interesting findings, it should be pointed out that the exact mechanism by which
LeTetR selectively controls the 3-hydroxylation step in the biosynthesis of HSAF is not completely
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understood. The results showed that the transcription level of the orf7 gene was not affected in the
orf3232 mutant ∆ORF3232, which mainly produced the 3-deOH precursors, with very little final
products (HSAF and alteramides). However, ORF7 is the main enzyme to convert the 3-deOH
precursors to the final products. The underlying mechanism for this observation is unclear, but one
possibility could be that orf3232 might regulate the translation or catalytic activity of the ORF7 enzyme.
The decreased level of HSAF and alteramides in the orf3232 mutant might be due to a decrease of
the functional enzymes, which was rescued by the E. coli-produced ORF7. More studies are needed
to tackle this fairly unusual LeTetR encoded by orf3232, which could reveal new insights into the
function of the TetR family regulators. Nevertheless, our results showed that the strain ∆ORF3232
could be used as a cell factory to generate the 3-deOH compounds, which are inactive precursors of
the final antifungal compounds, HSAF and alteramides. The wild-type OH11 produced a complex of
HSAF and analogs, which are controlled by a network of regulators and signals [8–18]. Small changes
in culture conditions could affect the production of the compounds. In contrast, strain ∆ORF3232
produced a relatively simple profile of compounds. Moreover, after the ORF7 extract was added to the
strain ∆ORF3232, the yield of the 3-deOH precursors decreased only slightly (~75% of that without
ORF7 extract), while the yield of HSAF and alteramides increased dramatically (14-fold and 13-fold,
respectively) (Figure 4). This indicated that exogenous ORF7 could not only convert the 3-deOH
precursors to the final compounds, but could also drive the strain ∆ORF3232 to continuously produce
these precursors. Thus, the overall yield of HSAF and alteramides could be significantly enhanced
using this method.
4. Materials and Methods
4.1. Bacterial Strains, Plasmids, and Growth Conditions
The bacterial strains and plasmids used in this study are shown in Table S1. The Luria–Bertani
(LB) broth medium was used for the growth of L. enzymogenes OH11 (CGMCC No. 1978). 1/10 TSB
(3 g TSB, per liter) was used for the RNA extraction and HSAF production. Plasmid pJQ200SK was
used for gene deletion and complementary in L. enzymogenes OH11 [21]. The Escherichia coli strain
XL-1 Blue was cultured at 37 ◦C in the LB medium supplemented with gentamicin (Gm, 50 g/mL)
to propagate plasmids. E. coli strain S17 was used for intergeneric conjugation. E. coli strain BL21
(DE3)/ORF7 was used for the ORF7 expression.
4.2. DNA Manipulation and Lysobacter Transformation
Chromosomal DNA and plasmids were isolated from L. enzymogenes OH11 or E. coli, according to
the standard techniques. Database search and sequence analysis were performed using the online
program PSI-BLAST. For the Lysobacter transformation, the recombination plasmid was introduced
into L. enzymogenes OH11 through intergeneric conjugation, using E. coli strain S17. After growing
on LB plates with Kanamycin (Km, 100 µg/mL) and Gentamicin (Gm, 150 µg/mL) at 30 ◦C for
72 h, the transformants were plated on the LB plates supplemented with 10% (w/v) sucrose and Km
(100 µg/mL). After growing at 30 ◦C for 72 h, the colonies were transferred into the LB plates containing
Km (100 µg/mL) or Km (100 µg/mL) + Gm (150 µg/mL). Finally, the Km-resistant and Gm-sensitive
strains were selected for PCR verification.
4.3. Primers and PCR
All primers used in this study were listed in Table S2. Phusion High-Fidelity DNA polymerase
(Thermo Scientific, Waltham, MA, USA) and Taq DNA polymerase (Thermo Scientific, Waltham, MA,
USA) were used for PCR program. For Phusion DNA polymerase, an initial denaturation at 98 ◦C
for 30 s was followed by 30 cycles of amplification (98 ◦C for 10 s, 60 ◦C for 15 s, 72 ◦C for 1 min),
and additional 5 min at 72 ◦C. For Taq DNA polymerase, an initial denaturation at 95 ◦C for 3 min was
followed by 30 cycles of amplification (95 ◦C for 30 s, 60 ◦C for 30 s, 72 ◦C for 1 min), and an additional
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10 min at 72 ◦C. Considering different DNA templates and primers, the annealing temperature and the
elongation time were changed in some cases.
4.4. Generation of the Deletion Mutant of orf3232 and Its Complementary Strain
The DNA fragments corresponding to the upstream and downstream region of orf3232 were
amplified using ORF3232UF/UR and ORF3232DF/DR. After treating the upstream region withXhoI/SpeI,
and treating the downstream region with BamHI/XhoI, the two DNA fragments were ligated into the
BamHI/SpeI sites of the plasmid pJQ200SK, to generate the recombination plasmid pJQ200SK::ORF3232.
The plasmid was introduced intoL. enzymogenesOH11 through intergeneric conjugation. After antibiotic
and sucrose screening, the transformants were used for PCR verification by primers ORF3232DF/UR
and ORF3232VFI/VRI (Figure S2).
For complementary analysis, the DNA fragment containing the upstream region, the downstream
region, and the orf3232 gene was amplified using primers ORF3232CF/UR. Then, the fragment was
treated withXhoI/SpeI and ligated into the same sites of plasmid pJQ200SK, to generate the recombination
plasmid pJQ200SK::ORF3232C. The recombination plasmid was transferred into the ∆ORF3232 strain
through intergeneric conjugation. After antibiotic and sucrose screening, the transformants were used
for PCR verification using primers ORF3232DF/UR and ORF3232VFI/VRI (Figure S3).
4.5. Construction of the Deletion Mutant of Fatty Acid Hydroxylase Genes
The DNA fragments corresponding to the upstream and downstream region of the fatty acid
hydroxylase genes (orf2195 or orf7 in HSAF biosynthetic gene cluster) were amplified using the primers
listed in Table S2. After treating with the restriction enzymes, the two DNA fragments were ligated into
the ApaI/SpeI sites of plasmid pJQ200SK, to generate the recombination plasmid pJQ200SK::ORF2195
or pJQ200SK::ORF7. The plasmid was introduced into L. enzymogenes OH11 through intergeneric
conjugation. After antibiotic and sucrose screening, the transformants were used for PCR verification
through the primers listed in Table S2 (Figures S6 and S7). To construct the double deletion mutant orf7
and orf2195, the plasmid pJQ200SK::ORF2195 was introduced into ∆ORF7 strain through intergeneric
conjugation. After antibiotic and sucrose screening, the transformants were used for PCR verification
by the primers listed in Table S2 (Figure S8).
4.6. RNA Extraction and Real-Time PCR
RNA was isolated from the OH11 WT, ∆ORF3232, and ORF3232CM strains cultured in 1/10 TSB
medium for 9, 24, and 36 h, as described previously [22]. After removing the contaminated DNA using
DNase I (Thermo Scientific, Waltham, MA, USA), RNA was reverse transcribed to the complementary
DNA using SuperScriptTM II RT reagent kit (Invitrogen, Carlsbad, CA, USA). Real-time PCR was
carried out in the CFX Connect Real-Time PCR Detection System (BIO-RAD Laboratories, Inc, Hercules,
CA, USA) using PowerUp SYBR Green Master Mix (Applied Biosystems, Foster, CA, USA), using the
primers listed in Table S2. The conditions were used as follows—50 ◦C for 2 min, 95 ◦C for 2 min,
followed by 40 cycles of 95 ◦C for 15 s and 60 ◦C for 1 min. The 16S rRNA was used as an internal
control. The relative transcriptional levels of the tested genes were normalized to 16S rRNA and
determined using the 2−44CT method [23].
4.7. Extraction and HPLC Analysis of HSAF and Its Analogs
OH11 WT, ∆ORF3232, and ORF3232CM strains were incubated into 1 mL LB at 30 ◦C with
overnight shaking at 200 rpm. An aliquot (1%) of the cultures was transferred to 25 mL 1/10 TSB,
at 30 ◦C with shaking at 200 rpm, for 48 h. The culture broths were treated with 75 µL formic acid and
25 mL ethyl acetate. The organic phase was dried with the air flow, and the residues were re-dissolved
in 200 µL methanol. A 20 µL aliquot of each extract was analyzed by HPLC (Agilent, 1220 Infinity
LC, Santa Clara, CA, USA). Water/0.05% formic acid (solvent A) and acetonitrile/0.05% formic acid
(solvent B) were used as the mobile phases with a flow rate of 1.0 mL/min. The HPLC program was as
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follows—5−25% B in 0−5 min, 25–80% B in 5−25 min, 80−100% B in 25−26 min, maintained to 28 min,
back to 5% B at 29 min, and maintained to 30 min. HSAF and its analogs were detected at 318 nm on a
UV detector.
4.8. Preparation of Protein Crude Extract Containing ORF7
The strain BL21 (DE3)/ORF7 [19] was incubated into LB containing 50 µg/mL kanamycin, and the
culture was grown at 37 ◦C with shaking at 250 rpm. When the optical density (OD600) of the culture
reached 0.6–0.7, the protein expression was induced with 1 mM IPTG. The cells were allowed to further
grow for 15 h at 16 ◦C. Finally, the cells were harvested through centrifugation at 4 ◦C and resuspended
in PBS (0.24 g KH2PO4, 1.44 g Na2HPO4, 8 g NaCl, 0.2 g KCl, pH 7.5, per liter), followed by sonication
and centrifugation. The supernatant containing ORF7 was used as the enzyme crude extract.
4.9. Exogenous Addition of the ORF7 Crude Extract to the ∆ORF3232 Strain
∆ORF3232 strain was incubated into 4 mL LB at 30 ◦C with overnight shaking at 200 rpm.
An aliquot (1%) of the cultures was transferred to 25 mL 1/10 TSB at 30 ◦C, with shaking at 200 rpm
for 48 h. After this, the ORF7 crude extract was added into the cultures, and incubated at 30 ◦C with
shaking at 200 rpm for 24 h. Then, the production of HSAF and its analogs was extracted and analyzed
using the above-mentioned method.
Supplementary Materials: The following are available online. Table S1: Bacterial strains and plasmids used
in this study. Table S2: Primers used in this study. Figure S1: The conserved domains in ORF3232. Figure S2:
Deletion of orf3232. Figure S3: Complementary strain of ∆ORF3232. Figure S4: Transcriptional analysis of the
HSAF biosynthetic genes, pks-nrps, orf7 and orf8. Figure S5: Alignment of the amino acid sequences of the
putative fatty acid hydroxylases in OH11. Figure S6: Deletion of orf2195. Figure S7: Deletion of orf7 of the HSAF
biosynthetic gene cluster. Figure S8: Deletion of both orf7 and orf2195.
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